Clinical trial
The Mechanism of Dexmedetomidine in Improving Delirium After Cardiac Surgery
NCT04127500 is registered in ClinicalTrials.gov with Nanjing First Hospital, Nanjing Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Mechanism of Dexmedetomidine in Improving Delirium After Cardiac Surgery
- Lead sponsor
- Nanjing First Hospital, Nanjing Medical University
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- August 1, 2019
- Completion date
- August 31, 2020
- Enrollment
- 200 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cardiac surgery, delirium, dexmedetomidine